A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.

Post-nasal drip occurs when mucus moves down your throat, causing irritation and cough. Here’s how medical professionals say you can stop it in its tracks.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Doctors shared their must-have sick season buys with The Post, revealing which medicines, supplements and tools you should ...

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.

Sinusitis, commonly known as a sinus infection, occurs when the nasal cavities become infected, swollen, and inflamed. While ...

The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major ...

Inhale steam from a bowl of hot water or take a warm shower to loosen mucus and soothe sinus pressure. Rinse nasal passages ...